Agorapulse is another strong contender in the social media management arena. It’s designed to be user-friendly, which is a ...

Patient enrollment and randomization for the trial was initiated in early 2025 and is expected to be completed in 2026. In ...

On May 7, 2025, Y-mAbs announced that naxitamab-gqgk (DANYELZA ®) has been recommended by the National Comprehensive Cancer Network ® ("NCCN”) Clinical Practice Guidelines in Oncology (NCCN Guidelines ...

CNW/ - Paramount Resources Ltd. ("Paramount" or the "Company") (TSX: POU) is pleased to announce its first quarter 2025 financial and operating results ...